NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
19/05/2026
Voltar para busca
Dado oficial do USPTO
ADIPEARL
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
34
Atualização mais recente
19/05/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 10
Data de depósito
20/06/2024
Data de registro
23/12/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
23/12/2025
Última transação
19/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
99
Localização do titular
Epalinges, CH
Examinador
GULIANO, ROBERT N
Localização atual
Historical data usage
Titulares e representantes
Titulares
Volumina Medical SA
Representantes
Amy C. Ziegler GREER, BURNS & CRAIN LTD.
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical polymers for use in the manufacture of pharmaceutical preparations and medical implants; biodegradable polymer compositions for use in the manufacture of pharmaceutical preparations and medical implants
Classe 5
Pharmaceutical preparationsin particular for tissue enhancement and reconstructionfor treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatology for aesthetic medicinefor reconstructive medicine and for reconstructive surgery; medical and veterinary preparations and articlesin particular medical and veterinary preparations for treating the loss of soft tissue volume as well as for improving skin quality and volume contours in dermatology for tissue enhancement and reconstruction; pre-filled syringes filled with pharmaceutical preparations for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatology for medical purposes; Pre-filled vials filled with pharmaceutical preparations for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatology for medical and aesthetic medicine purposes; vials and syringespre-filled with a medical preparation for enabling cellular or tissular assembly for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatology for aesthetic and medical purposes; injectable dermal fillers; biological implantsimplants comprising living tissue; implantable medicines for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatology; injectable materials in the nature of injectable gels for treating the loss of soft tissue volume in humans for tissue repairenhancementcreation or regeneration; implantable materials in the nature of injectable gels for treating the loss of soft tissue volume in humans containing an anaesthetic agent or a pharmaceutical ingredient; injectable materials in the nature of injectable gels for treating the loss of soft tissue volume in humans containing an anaesthetic agent or a pharmaceutical ingredient; none of the aforementioned in relation to medication and drugs for preventingcuring or slowing down the progression of cancer; polysaccharide compositions in the nature of injectable gels for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatology for use in the dermal filler industry; polymeric biomaterialsin particular polymeric biomaterials in the nature of injectable gels for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatology for use in the cell therapy industry; injectable biomaterials in the nature of injectable gels for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatologyin particular for use in aesthetic medicineaesthetic surgeryreconstructive surgery; injectable biomaterials in the nature of injectable gels for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatology in the form of microgels; injectable biomaterials in the nature of injectable gels for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatology in the form of particlesin the form of paste or puttyin the form of a dry material; implantable biomaterials in the nature of pharmaceutical preparations for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contoursin particular for enhancing or creating new skin volumes or skin layersin the form of three-dimensional volumes; injectable biocompatible material in the nature of injectable gels for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contoursin particular for enhancing or creating new skin volumes or skin layersin dermatology used for tissues in particular soft tissues
Classe 10
Surgical apparatus and instruments; prosthetic and filling materialsnamely artificial materials for use in the replacement of soft tissue in humansartificial implants; artificial breast implants; medical implants made of artificial materials; biodegradable implants consisting of artificial materials; scaffolding material for the use of three-dimensional shapeable body implantsimplantable scaffolds comprising artificial materials for creating new tissue volume or to compensate for tissue volume loss and serving as a scaffold for the regeneration of human tissue; artificial materials for the repair and enhancement of human tissueimplantable scaffolds comprising artificial materials for creating new tissue volume or to compensate for tissue volume loss and serving as a scaffold for the regeneration of human tissue; suture materials; syringes for injections; syringesvialscontainers and sterile bags sold together as medical apparatus for preparing a cellular or tissular constructfor preparing a pharmaceutical compositionfor mixing the composition with an anesthetic agent for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contoursin particular for enhancing or creating new skin volumes or skin layers in dermatology or plastic surgery for use in the dermal filler industry or tissue reconstruction and enhancement industryin the regenerative medicine industry; medical injection syringes; syringes for medical use; medical syringes for use in aesthetic surgeryin particularin dermatology and reconstructive surgery; pharmaceutical implants made of artificial materials; implants made of artificial materials for guided tissue regeneration.
Publicações
Histórico de despachos e eventos da marca no USPTO.
34 publicações encontradas
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
27/04/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
27/04/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
17/04/2026
ES7R
TEAS SECTION 7 REQUEST RECEIVED
15/01/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
23/12/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
23/12/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/11/2025
PUBO
PUBLISHED FOR OPPOSITION
04/11/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
29/10/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/10/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
15/09/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
15/09/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
15/09/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
15/09/2025
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
10/07/2025
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
10/07/2025
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
15/04/2025
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
15/04/2025
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
15/04/2025
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
15/04/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/03/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/03/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
27/03/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
14/01/2025
GNRT
NON-FINAL ACTION E-MAILED
14/01/2025
CNRT
NON-FINAL ACTION WRITTEN
14/01/2025
DOCK
ASSIGNED TO EXAMINER
14/01/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
13/01/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
24/09/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
24/09/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
24/09/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
24/09/2024
NWAP
NEW APPLICATION ENTERED
20/06/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ADIPEARL ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.